All Series B Shares are ordinary shares with full voting and economic rights. Series B
Shares do not provide the rights formerly provided by Series L Shares regarding appointment of directors as a class, preferential dividends and liquidation. Shareholders owning Series B Shares have the right to appoint and revoke at a general
shareholders meeting one member of the board of directors for each ten percent (10%) of the capital stock of the Registrant that they hold individually or in the aggregate. For a more detailed discussion, see Description of the
Registrants Series B Shares herein.
Capital Stock and Adjustments
The Reclassification did not result in a capital increase or decrease or in a change in the number of outstanding shares. However, the
Registrants outstanding capital stock is subject to adjustments resulting from repurchases and, prior to the Trading Date, from conversions.
Before giving effect to the Reclassification, the Registrants total authorized capital stock consisted of Ps. 239,356,431.73,
represented by 63,381,000,000 shares (including treasury shares), of which, as of December 20, 2022, (i) 488,305,718 are Series A Shares (with full voting rights); (ii) 20,554,697,460 are Series AA Shares (with full voting rights); and (iii)
42,337,996,822 are Series L Shares (with limited voting rights).
After giving effect to the Reclassification, the Registrants
outstanding capital stock is represented by a total of 63,381,000,000 Series B Shares (with full voting rights).
Description of the Registrants
Series B Shares
Below is a summary of certain provisions of the Registrants bylaws, as amended and restated to give effect to
the Reclassification, and Mexican law relating to the Series B Shares. This summary does not purport to be complete and is qualified by reference to the bylaws themselves. An English translation of the Registrants bylaws is attached as Exhibit
1.1 hereto.
Shareholders Equity
The Registrant has a single class of outstanding shares: the Series B Shares, which are without par value, fully paid and non-assessable.
Voting Rights
Each Series B Share entitles its holder to one (1) vote at any shareholders meeting and carries full voting rights.
Shareholder Meetings
The
Registrants shareholders meetings may be ordinary or extraordinary. Extraordinary general meetings are those called to consider certain specified matters, including, principally, changes to the bylaws, liquidation, merger and change of
corporate form, as well as to consider the removal of the Registrants shares from the National Securities Registry maintained by the CNBV. General meetings called to consider all other matters are ordinary meetings.
The Registrant will hold an ordinary general shareholders meeting each year to consider the approval of the financial statements for the
preceding fiscal year, to elect directors and to determine the allocation of the profits. Transactions that represent 20.0% or more of the Registrants consolidated assets in any fiscal year will continue to require approval by an ordinary
general meeting of all shareholders.
At first call, the quorum for an ordinary general shareholders meeting will be 50.0% of the
outstanding shares, and action may be taken by a majority of the shares present. If a quorum is not available at first call, a second meeting may be called at which action may be taken by a majority of the shares present, regardless of the number of
such shares. The quorum for an extraordinary shareholders meeting will be 75.0% of the outstanding shares. If a quorum is not available at first call, a second meeting may be called and quorum will be met, provided a majority of the
outstanding shares is present. Whether on a first or second call, in order for the actions taken at an extraordinary shareholders meeting to be valid, such actions must be approved, at a minimum, by the affirmative vote of 50.0% of the
outstanding shares.
2